» Articles » PMID: 28981090

Is Trehalose an Autophagic Inducer? Unraveling the Roles of Non-reducing Disaccharides on Autophagic Flux and Alpha-synuclein Aggregation

Overview
Journal Cell Death Dis
Date 2017 Oct 6
PMID 28981090
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Autophagy is a pivotal intracellular process by which cellular macromolecules are degraded upon various stimuli. A failure in the degradation of autophagic substrates such as impaired organelles and protein aggregates leads to their accumulations, which are characteristics of many neurodegenerative diseases. Pharmacological activation of autophagy has thus been considered a prospective therapeutic approach for treating neurodegenerative diseases. Among a number of autophagy-inducing agents, trehalose has received attention for its beneficial effects in different disease models of neurodegeneration. However, how trehalose promotes autophagy has not been fully revealed. We investigated the influence of trehalose and other disaccharides upon autophagic flux and aggregation of α-synuclein, a protein linked to Parkinson's disease. In differentiated human neuroblastoma and primary rat cortical neuron culture models, treatment with trehalose and other disaccharides resulted in accumulation of lipidated LC3 (LC3-II), p62, and autophagosomes, whereas it decreased autolysosomes. On the other hand, addition of Bafilomycin A1 to trehalose treatments had relatively marginal effect, an indicative of autophagic flux blockage. In concordance with these results, the cells treated with trehalose exhibited an incremental tendency in α-synuclein aggregation. Secretion of α-synuclein was also elevated in the culture medium upon trehalose treatment, thereby significantly increasing intercellular transmission of this protein. Despite the substantial increase in α-synuclein aggregation, which normally leads to cell death, cell viability was not affected upon treatment with trehalose, suggesting an autophagy-independent protective function of trehalose against protein aggregates. This study demonstrates that, although trehalose has been widely considered an autophagic inducer, it may be actually a potent blocker of the autophagic flux.

Citing Articles

How close is autophagy-targeting therapy for Alzheimer's disease to clinical use? A summary of autophagy modulators in clinical studies.

Fernandes S, Mayer J, Nilsson P, Shimozawa M Front Cell Dev Biol. 2025; 12():1520949.

PMID: 39845082 PMC: 11750832. DOI: 10.3389/fcell.2024.1520949.


Trehalose: Neuroprotective Effects and Mechanisms-An Updated Review.

Sevriev B, Dimitrova S, Kehayova G, Dragomanova S NeuroSci. 2024; 5(4):429-444.

PMID: 39484301 PMC: 11503274. DOI: 10.3390/neurosci5040032.


To eat or not to eat: a critical review on the role of autophagy in prostate carcinogenesis and prostate cancer therapeutics.

Kurganovs N, Engedal N Front Pharmacol. 2024; 15:1419806.

PMID: 38910881 PMC: 11190189. DOI: 10.3389/fphar.2024.1419806.


PEG 400:Trehalose Coating Enhances Curcumin-Loaded PLGA Nanoparticle Internalization in Neuronal Cells.

Caballero-Floran I, Cortes H, Borbolla-Jimenez F, Floran-Hernandez C, Del Prado-Audelo M, Magana J Pharmaceutics. 2023; 15(6).

PMID: 37376043 PMC: 10304145. DOI: 10.3390/pharmaceutics15061594.


Trehalose attenuates abdominal aortic aneurysm formation by inducing autophagy in smooth muscle cells.

Jiang B, Li X, Wang M, Li G, Ren P, Wang Y J Geriatr Cardiol. 2023; 20(3):214-222.

PMID: 37091261 PMC: 10114191. DOI: 10.26599/1671-5411.2023.03.002.


References
1.
Lee H, Cho E, Lee K, Kim J, Cho S, Lee S . Autophagic failure promotes the exocytosis and intercellular transfer of α-synuclein. Exp Mol Med. 2013; 45:e22. PMC: 3674407. DOI: 10.1038/emm.2013.45. View

2.
Osellame L, Duchen M . Defective quality control mechanisms and accumulation of damaged mitochondria link Gaucher and Parkinson diseases. Autophagy. 2013; 9(10):1633-5. DOI: 10.4161/auto.25878. View

3.
Banerjee R, Beal M, Thomas B . Autophagy in neurodegenerative disorders: pathogenic roles and therapeutic implications. Trends Neurosci. 2010; 33(12):541-9. PMC: 2981680. DOI: 10.1016/j.tins.2010.09.001. View

4.
Martin P . Glycobiology of the synapse. Glycobiology. 2002; 12(1):1R-7R. DOI: 10.1093/glycob/12.1.1r. View

5.
Klionsky D, Elazar Z, Seglen P, Rubinsztein D . Does bafilomycin A1 block the fusion of autophagosomes with lysosomes?. Autophagy. 2008; 4(7):849-50. DOI: 10.4161/auto.6845. View